Rapid effects of aldosterone: Relevant in cardiac ischemia?

Hypertension

Volumn 46, Issue 1, 2005, Pages 27-28

  Wehling, Martin ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; CALCIUM; EPLERENONE; HORMONE RECEPTOR; MINERALOCORTICOID; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOLIPASE C; PROGESTERONE; PROTEIN KINASE; SPIRONOLACTONE; STEROID HORMONE; VITAMIN D;

CALCIUM CELL LEVEL; CARDIOVASCULAR EFFECT; CELL PH; DEATH; DISEASE COURSE; EDITORIAL; GENOMICS; HEART MUSCLE ISCHEMIA; HUMAN; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ALDOSTERONE; ANIMALS; HUMANS; MYOCARDIAL ISCHEMIA; TIME FACTORS;

EID: 21744451312     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000171161.60967.ab     Document Type: Editorial

References (12)

1. Fujita M, Minamino T, Asanuma H, Sanada S, Hirata A, Wakeno M, Myoishi M, Okuda H, Takashima S, Okada K, Tsukamoto O, Koyama H, Hori M, Kitakaze M. Nongenomic actions of aldosterone rapidly deteriorate canine ischemic hearts via PKC-dependent pathways. Hypertension. 2005;46:113-117.
2. Selye H. Correlation between the chemical structure and the pharmacological actions of the steroids. Endocrinology. 1942;30:437-453.
3. Ganong WF, Mulrow PJ. Rate of change in sodium and potassium excretion after injection of aldosterone into the aorta and renal artery of the dog. Am J Physiol. 1958;195:337-351.
4. Spach C, Streeten DH. Retardation of sodium exchange in dog erythrocytes by physiological concentrations of aldosterone, in vitro. J Clin Invest. 1964;43:217-227.
5. Losel RM, Falkenstein E, Feuring M, Schultz A, Tillmann HC, Rossol-Haseroth K, Wehling M. Nongenomic steroid action: controversies, questions, and answers. Physiol Rev. 2003;83:965-1016.
6. Callera GE, Touyz RM, Tostes RC, Yogi A, He Y, Malkinson S, Schiffrin EL. Aldosterone activates vascular p38MAP kinase and NADPH oxidase via c-Src. Hypertension. 2005;45:773-779.
7. Thomas P, Pang Y, Filardo EJ, Dong J. Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. Endocrinology. 2005;146:624-632.
8. Funder JW. The nongenomic actions of aldosterone. Endocr Rev. 2005 (April). [Epub ahead of print].
9. Schmidt BM, Georgens AC, Martin N, Tillmann HC, Feuring M, Christ M, Wehling M. Interaction of rapid nongenomic cardiovascular aldosterone effects with the adrenergic system. J Clin Endocrinol Metab. 2001;86:761-767.
10. Arima S, Kohagura K, Xu HL, Sugawara A, Uruno A, Satoh F, Takeuchi K, Ito S. Endothelium-derived nitric oxide modulates vascular action of aldosterone in renal arteriole. Hypertension. 2004;43:352-357.
11. Schmidt BM, Oehmer S, Delles C, Bratke R, Schneider MP, Klingbeil A, Fleischmann EH, Schmieder RE. Rapid nongenomic effects of aldosterone on human forearm vasculature. Hypertension. 2003;42:156-160.
12. Doolan CM, Harvey BJ. Modulation of cytosolic protein kinase C and calcium ion activity by steroid hormones in rat distal colon. J Biol Chem. 1996;271:8763-8767.